Impact of the growth hormone receptor exon 3 deletion gene polymorphism on glucose metabolism, lipids, and insulin-like growth factor-I levels during puberty

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 8, 2009, Pages 2966-2969

  Sørensen, Kaspar ^a   Aksglaede, Lise ^a   Munch Andersen, Thor ^a   Aachmann Andersen, Niels Jacob ^a   Leffers, Henrik ^a   Helge, Jørn Wulff ^b   Hilsted, Linda ^a   Juul, Anders ^a  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE RECEPTOR; LIPID; SOMATOMEDIN C;

ADOLESCENT; ALLELE; ARTICLE; CHILD; DNA POLYMORPHISM; EXON; FEMALE; GENE DELETION; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD;

EID: 68549117055     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0313     Document Type: Article

References (18)

1. Nielsen JH, Linde S, Welinder BS, Billestrup N, Madsen OD 1989 Growth hormone is a growth factor for the differentiated pancreatic β-cell. Mol Endocrinol 3:165-173
2. Jorgensen JO, Moller L, Krag M, Billestrup N, Christiansen JS 2007 Effects of growth hormone on glucose and fat metabolism in human subjects. Endocrinol Metab Clin North Am 36:75-87
3. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ 2002 Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359:1740-1745
4. Carmichael JD, Danoff A, Milani D, Roubenoff R, Lesser ML, Livote E, Reitz RE, Ferris S, Kleinberg DL 2006 GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90. Clin Endocrinol (Oxf) 65:169-177
5. Jensen RB, Vielwerth S, Larsen T, Greisen G, Leffers H, Juul A 2007 The presence of the d3-growth hormone receptor polymorphism is negatively associated with fetal growth but positively associated with postnatal growth in healthy subjects. J Clin Endocrinol Metab 92:2758-2763
6. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P 2004 A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36:720-724
7. Mericq V, Roman R, Iniguez G, Angel B, Salazar T, Avila A, Perez-Bravo F, Cassorla F 2007 Relationship between nocturnal growth hormone concentrations, serum IGF-I/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children. Horm Res 68:132-138
8. Audi L, Carrascosa A, Esteban C, Fernandez-Cancio M, Andaluz P, Yeste D, Espadero R, Granada ML, Wollmann H, Fryklund L 2008 The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective study. J Clin Endocrinol Metab 93:2709-2715
9. Strawbridge RJ, Karvestedt L, Li C, Efendic S, Ostenson CG, Gu HF, Brismar K 2007 GHR exon 3 polymorphism: association with type 2 diabetes mellitus and metabolic disorder. Growth Horm IGF Res 17:392-398
10. Sorensen K, Aksglaede L, Munch-Andersen T, Aachmann-Andersen NJ, Petersen JH, Hilsted L, Helge JW, Juul A 2009 Sex hormone-binding globulin levels predict insulin sensitivity, disposition index and cardiovascular risk during puberty. Diabetes Care 32:909-914
11. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470
12. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van HT, Renn W, Gerich J 2000 Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295-301
13. Bergman RN, Ader M, Huecking K, Van Citters G 2002 Accurate assessment of β-cell function: the hyperbolic correction. Diabetes 51(Suppl 1):S212-S220
14. Kahn SE 2003 The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3-19
15. Retnakaran R, Shen S, Hanley AJ, Vuksan V, Hamilton JK, Zinman B 2008 Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity (Silver Spring) 16:1901-1907
16. Pantel J, Machinis K, Sobrier ML, Duquesnoy P, Goossens M, Amselem S 2000 Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. J Biol Chem 275:18664-18669
17. Goran MI, Gower BA 2001 Longitudinal study on pubertal insulin resistance. Diabetes 50:2444-2450
18. Burke GL, Webber LS, Srinivasan SR, Radhakrishnamurthy B, Freedman DS, Berenson GS 1986 Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: Bogalusa Heart Study. Metabolism 35:441-446